STE Steris

Q3 2025 10-Q

Filed: Nov 6, 2025Period ending Sep 30, 2025

Health Care

Orthopedic, Prosthetic & Surgical Appliances & SuppliesSEC EDGAR

Steris (STE) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

• No newly added risk factors or significant changes to risk profile disclosed compared to most recent 10-K
• Regulatory risk from taxation includes potential impact of changes in tax law necessitating revision of past tax estimates

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.5B

▲ +9.9% YoY▲ +5.0% QoQ

Net Income

$192M

▲ +27.8% YoY▲ +8.1% QoQ

Net Margin

13.1%

▲ +184bp YoY▲ +38bp QoQ

Source: XBRL data from Steris Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Steris Quarterly Reports

Q4 2025 10-Q

Get deeper insights on Steris

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.